>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
不同时期ICU脓毒症患者临床特征及转归分析
作者:李国民1  管双仙1  万健2  袁冬1  王建强1  杨建军3 
单位:1. 江苏大学附属金坛医院 ICU,江苏 金坛 213200;
2. 上海瑞金医院集团闵行医院 ICU, 上海 201100;
3. 南京军区南京总医院 麻醉科,江苏 南京 210002
关键词:脓毒症 临床特征 重症监护病房 早期目标导向治疗 病死率 
分类号:R631
出版年·卷·期(页码):2012·31·第五期(546-550)
摘要:

目的:分析不同时期ICU脓毒症患者临床特征及治疗转归。方法:采用前瞻法研究,与历史病例进行对照比较研究;前瞻性观察组(前瞻组)为2010年1月至2011年12月ICU脓毒症患者,历史对照组(对照组)为2006年1月至2007年12月ICU的脓毒症患者,前瞻组401例,对照组285例,组内按疾病严重程度再分为普通脓毒症、严重脓毒症、脓毒症休克3层;前瞻组在诊断脓毒症后最初6h内作早期目标性复苏(EGDT)等治疗,对照组通过查阅病历采集数据。结果:两组普通脓毒症、严重脓毒症、脓毒症休克病例的APACHEⅡ评分与疾病严重程度呈正相关(P<0.01);前瞻组严重脓毒症、脓毒症休克患者住ICU天数、病死率低于对照组(P<0.05);两组脓毒症感染部位均依次为呼吸系统、腹腔、血液及其他部位,血液感染脓毒症病死率居首位;前瞻组总病死率低于对照组(P<0.05)。结论:脓毒症是ICU主要收治病种,病死率高;对严重脓毒症、脓毒症休克患者进行早期积极规范的综合治疗可以降低该类患者的病死率。

Objective: To analyze the clinical features and treatment outcomes of sepsis in the different periods in ICU. Methods: Observing the sepsis patients with a prospective design, and comparing with the historical cases. The prospective observational sepsis group(prospective group) cases were collected from January 2010 to December 2011, and historical control group(control group) cases were gathered from January 2006 to December 2007. There were 401 cases in the prospective group and 285 cases in the control group. According to the severity of sepsis, the cases were divided into general sepsis, severe sepsis and septic shock three levels. Prospective group were treated with the early goal-directed therapy(EGDT) and other measurement within 6 hours after the diagnosis of sepsis, control group data was gathered from medical historical records. Results: The APACHE II score was positively correlated to the severity of sepsis(P<0.01). The days staying in ICU and mortality rates of patients of severe sepsis, septic shock in prospective group were lower than those in the control group(P<0.05). The sites of infection in two groups were followed by respiratory, abdominal cavity, blood and other parts. The top mortality of sepsis was the blood infection. The total mortality rate in prospective group was lower than that in the control group(P<0.05). Conclusion: Sepsis patients are the main target who needs to be treated in ICU for its severity and high mortality. An active regulatory early treatment can reduce mortality of patients with severe sepsis and septic shock.

参考文献:

[1] LEVY M M,FINK M P,MARSHALL J C,et al.2001 SCCM /ESICM /AC-CP/ATS/SIS International Sepsis Definitions Conference[J].Crit Care Med,2003,31(4):1250-1256.
[2] DELLINGER R P,LEVY M M,CARLET J M.et al.Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock:2008[J].Crit Care Med,2008,36(1):296-327.
[3] 王鸣,彭炜,蔡敏,等.外科重症监护室645例脓毒症患者临床流行病学调查[J].中国危重病急救医学,2006,18(2):74-77.
[4] ENGEL C,BRUNKHORST F M,BONE H G,et al.Epidemiology of sepsis in Germany:results from a national prospective multicenter study[J].Intensive Care Med,2007,33(4):606-618.
[5] FINFER S,BELLOMO R,LIPMAN J,et al.Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units[J].Intensive Care Med,2004,30(4):589-596.
[6] PADKIN A,GOLDFRAD C,BRADY A R,et al.Epidemiology of severe sepsis occurring in the first 24 hours in ICU in England,Wales and Northern Ireland[J].Crit Care Med,2003,31(9):2332-2338.
[7] STPHANE H,SAX H,PHILIPPE E A,et al.Nosocomial Bloodstream infection and clinical sepsis[J].Emerg infect dis,2004,10(1):76-81.
[8] NGUYEN H B,CORBETT S W,STEELE R,et al.Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality[J].Crit Care Med,2007,35(4):1105-1112.
[9] 严静,刘大为.降低严重感染与感染性休克的病死率:机遇与挑战并[J].中国危重病急救医学,2007,19(3):插页.
[10] CARTER C.Implementing the severe sepsis care bundles outside the ICU by outreach[J].Nurs Crit Care,2007,12(5):225-230.
[11] RIVERS E,NGUYEN B,HAVSTAD S.Early goal-directed therapy in the treatment of severe sepsis and septic shock[J].N Engl N Med,2001,345:1368-1377.
[12] 严静.严重脓毒症早期目标指导性治疗:亟待规范[J].中国实用外科杂志,2009,29(12):974-975.
[13] 纪国业,王斌,杜江,等.不同时间血液灌流对脓毒症兔血IL-6及TNF-α的影响[J].现代医学,2011,39(2):129-133.
[14] 李国民,吴晶,袁冬,等.去甲肾上腺素联合左西蒙旦或多巴酚丁胺对脓毒性休克猪的影响[J].东南大学学报:医学版,2011,30(6):892-895.
[15] 戴林峰,王醒.脓毒症与凝血功能异常[J].东南大学学报:医学版,2012,31(3):359-362.
[16] 陈齐红,郑瑞强,林华,等.感染性休克集束治疗对病死率影响的前瞻性研究[J].中国危重病急救医学,2008,20(9):534-537.
[17] 郭琦,黎敏毅,农凌波,等.严重感染集束治疗的依从性研究[J].中国危重病急救医学,2009,21(1):8-12.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 405518 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364